IDCRC Investigator Profile: Carlos del Rio, MD

Carlos del Rio is a Distinguished Professor of Medicine at Emory University School of Medicine and professor of global health and epidemiology at Emory’s Rollins School of Public Health. He is also co-director of the Emory Center for AIDS Research (CFAR) and co-PI of the Emory-CDC HIV Clinical Trials Unit and the Emory Vaccine and Treatment Evaluation Unit. As of October 2022, del Rio serves as the President of the Infectious Diseases Society of America (IDSA).

How long have you worked with a VTEU?

I joined the Emory VTEU during the most recent re-competition when Nadine Rouphael, Evan Anderson, and I became the co-PIs of the unit.

Briefly describe the IDCRC-supported trials you’ve worked on

I have worked on several COVID-19 vaccine studies, including Moderna and Novavax. Learn more about IDCRC Studies.

Of these trials, what has been the most impactful or highlight of the work?

Being involved in the rapid development of a COVID vaccine in the middle of a pandemic was both incredibly challenging and exhilarating.  

What is a strength or example of the importance of the IDCRC during the pandemic and beyond?

The IDCRC is the hub of the VTEUs. The scientific and administrative leadership provided by the IDCRC is critical for the success of the program.

What do you like to do outside of the VTEU?

I do many things outside of work but a major one is my involvement with the arts. I am on the Board of the Atlanta Symphony Orchestra and the Atlanta Opera – working with them is both relaxing and enjoyable.